ATTO

NASDAQ 已收盘

Attovia Therapeutics

15.13 USD
▼-0.68-4.30%
盘后 15.22 +0.56%
2026-11-13
市值
$690.70M
市盈率
—
EPS
-7.49
股息率
—
52 周区间
12.94 – 28.00
成交量
322.87K
Beta
1.52
目标价
43.20
52W 低 12.9452W 高 28.00
价格走势

公司简介

Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company’s products include ATTO-1310, a novel ATTOBODY-based Fc-fusion protein therapeutic that inhibits IL-31; developed for the treatment of chronic pruritic diseases such as CPUO, high-itch AD, cholestatic pruritus, and CKD-aP; ATTO-2306, an ATTOBODY-based, half-life-extended immunoglobuli...

关联新闻